PROMUS Element Plus US Post-Approval Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2681 participants.

Also called NCT01589978

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,681 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01589978
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01589978. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2016-05-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PROMUS Element Plus US Post-Approval Study
Intervention (Device)
PROMUS Element Plus Coronary Stent System
Intervention (Drug)
Aspirin
Intervention (Drug)
P2Y12 antagonist
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01589978
Content hash
e06cc35bd8d2d3b5fc86786217da0b8646ae56c413de64901f9e6da407997667